We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score

    Adoptively transferred T cell receptor-engineered T cells are a promising cancer treatment strategy, and the identification of tumour-specific TCRs...

    Chaoting Zhang, Shance Li, ... Zheming Lu in Cancer Immunology, Immunotherapy
    Article Open access 10 May 2024
  2. Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

    Although T cells can develop into an exhausted state in the tumour microenvironment, tumour infiltrating T cells (TILs) are important to control...

    Alistair L. J. Symonds, Tizong Miao, ... ** Wang in Cancer Immunology, Immunotherapy
    Article Open access 07 November 2022
  3. Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis

    Wnt/β-catenin signalling is aberrantly activated in most colorectal cancer (CRC) and is one key driver involved in the initiation and progression of...

    Xue Li, Yulin Chen, ... **anming Mo in Oncogene
    Article Open access 22 March 2024
  4. Circulating tumour cells for early detection of clinically relevant cancer

    Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early detection are paramount to reducing cancer-related...

    Rachel Lawrence, Melissa Watters, ... Yong-Jie Lu in Nature Reviews Clinical Oncology
    Article 02 June 2023
  5. The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer—Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination

    Background

    According to the common tenet, tumour progression is a chronological process starting with lymphatic invasion. In this respect, the meaning...

    Michaela Ramser, Rene Warschkow, ... Benjamin Weixler in World Journal of Surgery
    Article Open access 27 December 2021
  6. XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models

    Background

    Additional immunotherapies are still warranted for non-responders to checkpoint inhibitors with refractory or relapsing cancers, especially...

    Bochun Wang, Yujie Liu, ... **n Gao in Cancer Immunology, Immunotherapy
    Article 21 October 2023
  7. Cancer metastasis chemoprevention prevents circulating tumour cells from germination

    The war against cancer traces back to the signature event half-a-century ago when the US National Cancer Act was signed into law. The cancer crusade...

    **aodong **e, Yumei Li, ... Lee Jia in Signal Transduction and Targeted Therapy
    Article Open access 02 October 2022
  8. Brown Tumour of the Premaxilla

    Brown tumours of the head and neck region are rare. They occur in the setting of increased secretion of parathormone (PTH) from hyper functioning...

    Deepika Kenkere, Abhay K. Kattepur, Kalyani R in Indian Journal of Surgery
    Article 20 May 2024
  9. Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids

    Nicotinamide N -methyltransferase (NNMT) has been reported to be linked to methylation reprogramming in cancer cells. However, the role of NNMT in the...

    Hui Zhao, Rui Li, ... Zhengjun Shang in Oncogene
    Article 23 February 2023
  10. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

    B cells are a major component of the tumour microenvironment, where they are predominantly associated with tertiary lymphoid structures (TLS). In...

    Wolf H. Fridman, Maxime Meylan, ... Catherine Sautès-Fridman in Nature Reviews Clinical Oncology
    Article 01 April 2022
  11. Melanotic Neuroectodermal Tumour of Infancy

    Melanotic neuroectodermal tumour of infancy (MNTI) is a locally aggressive neoplasm of neural crest origin. It is primarily a paediatric tumour, and...

    Mahija Janardhanan, S. Rakesh, ... V. Ravi in Head and Neck Pathology
    Article 28 February 2023
  12. Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer

    Epithelial ovarian cancer (EOC) is the gynaecological malignancy with highest mortality. Although adjuvant treatment with carboplatin and paclitaxel...

    Gabriel Lindahl, Sebastian Fjellander, ... Lasse Jensen in npj Precision Oncology
    Article Open access 27 February 2024
  13. Hallmark discoveries in the biology of Wilms tumour

    The modern study of Wilms tumour was prompted nearly 50 years ago, when Alfred Knudson proposed the ‘two-hit’ model of tumour development. Since...

    Daniela Perotti, Richard D. Williams, ... Kathy Pritchard-Jones in Nature Reviews Urology
    Article 17 October 2023
  14. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

    Reversible transition between the epithelial and mesenchymal states are key aspects of carcinoma cell dissemination and the metastatic disease, and...

    Amador Gallardo, Aldara Molina, ... David Landeira in Oncogene
    Article 09 June 2022
  15. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation

    Interleukin (IL)-33 is an important cytokine in the tumour microenvironment; it is known to promote the growth and metastasis of solid cancers, such...

    Graziela Perri, Vanessa Garcia Vilas Boas, ... Ana Paula Campanelli in Cancer Immunology, Immunotherapy
    Article Open access 25 April 2024
  16. γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function

    Γδ T cell infiltration into tumours usually correlates with improved patient outcome, but both tumour-promoting and tumoricidal effects of γδ T cells...

    William Rodin, Louis Szeponik, ... Marianne Quiding Järbrink in Cancer Immunology, Immunotherapy
    Article Open access 02 July 2024
  17. Tumour cell-activated platelets modulate the immunological activity of CD4+, CD8+, and NK cells, which is efficiently antagonized by heparin

    Platelets, key players in haemostasis, are progressively investigated with respect to their role in immunity and inflammation. Although the platelet...

    Lukas M. Gockel, Katrin Nekipelov, ... Martin Schlesinger in Cancer Immunology, Immunotherapy
    Article Open access 14 March 2022
  18. Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice

    Collagen expression and structure in the tumour microenvironment are associated with tumour development and therapy response. Leukocyte-associated...

    Akashdip Singh, Eline T. A. M. Mommers-Elshof, ... M. Ines Pascoal Ramos in Cancer Immunology, Immunotherapy
    Article Open access 18 January 2024
  19. Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer

    Ovarian cancer is a major cause of death among all gynaecological cancers. Although surgery, chemotherapy and targeted therapy have yielded...

    Ke Li, **g Xu, ... Yu Kang in Cancer Immunology, Immunotherapy
    Article Open access 27 September 2022
  20. Giant cell-rich solitary fibrous tumour of the urinary bladder: case report of an unusual histological variant and literature review

    Background

    Giant cell-rich solitary fibrous tumour (GCR-SFT), previously referred to as giant cell angiofibroma, is an uncommon soft tissue tumour...

    Zhou Su, Jianguo Wei, **aolu Yuan in Diagnostic Pathology
    Article Open access 23 January 2024
Did you find what you were looking for? Share feedback.